Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥1.68 - CN¥2.95
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CN¥26.90B |
EV | CN¥26.09B |
Shares Outstanding | 13.86B |
Beta | 0.60 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 7.70% |
EPS | -89.80% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | 0.12% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Kangmei Pharmaceutical Co., Ltd.
600518
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Liu, Guowei
Employees
4,409
Website
www.kangmei.com.cnIPO Date
2001-03-19
Headquarters
Taike Road, Xiameilin, Futian District, Shenzhen, Guangdong Province, 518000, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved